Frontier Wealth Management’s VBI Vaccines, Inc. New Common Stock (Canada) VBIV Stock Holding History

Frontier Wealth Management’s Portfolio VBIV Stock Details VBIV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	$487K	Hold	20,060	–	–	0.04%	243
2022 Q1	$951K	Buy	20,060 +18,860	+1,572%	+$932K	0.01%	185
2021 Q4	$84K	Hold	1,200	–	–	0.01%	416
2021 Q3	$112K	Sell	1,200 -20,000	-94%	-$1.9M	0.01%	409
2021 Q2	$2.13M	Hold	21,200	–	–	0.15%	115
2021 Q1	$1.98M	Hold	21,200	–	–	0.15%	108
2020 Q4	$1.75M	Buy	21,200 +1,200	+6%	+$102K	0.14%	111
2020 Q3	$1.72M	Hold	20,000	–	–	0.16%	105
2020 Q2	$1.86M	Buy	+20,000	New	+$1.1M	0.17%	101

Other funds holding VBIV

Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Cambridge Investment Research Advisors Fairfield, Iowa $44.6B AUM 28.94% 1-Year Est. Return

GAI

General American Investors New York $1.69B AUM 40.94% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Frontier Wealth Management's VBIV Position: Q2 2022 in Review

Frontier Wealth Management held its VBI Vaccines, Inc. New Common Stock (Canada) (VBIV) position steady in Q2 2022 at 20,060 shares worth $487K. The position accounts for 0.04% of the portfolio, ranked #243.

Frontier Wealth Management first reported a position in VBIV in Q2 2020 and has held it in 9 quarters since. The position peaked at $2.13M in Q2 2021. 130 funds tracked by Wall St. Rank hold VBIV as of Q2 2022.

Frontier Wealth Management held 20,060 shares of VBI Vaccines, Inc. New Common Stock (Canada) worth $487K as of Q2 2022.
Frontier Wealth Management left its VBI Vaccines, Inc. New Common Stock (Canada) share count unchanged in Q2 2022.
VBI Vaccines, Inc. New Common Stock (Canada) made up 0.04% of Frontier Wealth Management's portfolio in Q2 2022, its #243 holding.
Frontier Wealth Management first reported a position in VBI Vaccines, Inc. New Common Stock (Canada) in Q2 2020 and has held it in 9 quarters since.
Frontier Wealth Management's VBI Vaccines, Inc. New Common Stock (Canada) position peaked at $2.13M in Q2 2021.
130 funds tracked by Wall St. Rank held VBI Vaccines, Inc. New Common Stock (Canada) as of Q2 2022.

Based on Frontier Wealth Management's 13F filing for Q2 2022, filed 12 Aug 2022.